CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8550
-0.1000 (-10.47%)
Sep 28, 2026, 12:11 PM EDT - Market open
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $10.12 million as of September 28, 2026. Its market cap has decreased by -55.94% in one year.
Market Cap
10.12M
Enterprise Value
8.86M
1-Year Change
-55.94%
Ranking
Category
Stock Price
$0.86
ChartMarket Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $10.12M, a decrease of -78.06%. That is a compound annual growth rate of -35.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 10.12M | -34.33% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioVie | 12.11M |
| CalciMedica | 11.95M |
| Daré Bioscience | 11.86M |
| IN8bio | 11.83M |
| Phio Pharmaceuticals | 11.73M |
| Moleculin Biotech | 11.72M |
| Moolec Science | 11.65M |
| BioLineRx | 11.17M |